MENU
+Compare
ROIV
Stock ticker: NASDAQ
AS OF
Dec 18, 02:03 PM (EDT)
Price
$12.01
Change
-$0.14 (-1.15%)
Capitalization
8.84B

ROIV Roivant Sciences Ltd Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ROIV with price predictions
Dec 17, 2024

ROIV in upward trend: 10-day moving average crossed above 50-day moving average on November 25, 2024

The 10-day moving average for ROIV crossed bullishly above the 50-day moving average on November 25, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 49 cases where ROIV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on ROIV as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ROIV moved above its 50-day moving average on December 16, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 147 cases where ROIV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ROIV moved out of overbought territory on December 02, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for ROIV turned negative on December 10, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ROIV broke above its upper Bollinger Band on November 22, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.716) is normal, around the industry mean (14.664). P/E Ratio (2.193) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). ROIV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (76.923) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROIV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ROIV is expected to report earnings to fall 13.32% to -21 cents per share on February 17

Roivant Sciences Ltd ROIV Stock Earnings Reports
Q4'24
Est.
$-0.22
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.36
Q1'24
Beat
by $0.09
Q4'23
Beat
by $6.34
The last earnings report on November 12 showed earnings per share of -25 cents, missing the estimate of -23 cents. With 832.54K shares outstanding, the current market capitalization sits at 8.84B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QTJA25.060.03
+0.14%
Innovator Growth Accelerated Pls ETF Jan
SUSB24.80-0.02
-0.08%
iShares ESG 1-5 Year USD Corp Bd ETF
EMXC57.03-0.58
-1.01%
iShares MSCI Emerging Mkts ex China ETF
SHOC47.49-0.65
-1.35%
Strive U.S. Semiconductor ETF
TSME38.33-0.58
-1.49%
Thrivent Small-Mid Cap ESG ETF

ROIV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.41%
IMVT - ROIV
57%
Loosely correlated
+1.01%
ARGX - ROIV
46%
Loosely correlated
+0.90%
AXON - ROIV
43%
Loosely correlated
-2.09%
RARE - ROIV
41%
Loosely correlated
-0.99%
PGEN - ROIV
41%
Loosely correlated
+2.46%
More